Klinique Med Financials
| KLINIQ Stock | 30.50 0.50 1.61% |
Klinique |
Please note, the presentation of Klinique Med's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Klinique Med's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Klinique Med's management manipulating its earnings.
| Instrument | Thailand Stock View All |
| Exchange | Thailand Exchange |
| Business Address | 2922307-308 Charn Issara |
| Sector | Consumer Cyclical |
| Industry | Personal Services |
| Benchmark | Dow Jones Industrial |
| Website | www.theklinique.com |
| Phone | 66 80 000 9800 |
You should never invest in Klinique Med without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Klinique Stock, because this is throwing your money away. Analyzing the key information contained in Klinique Med's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Klinique Med Key Financial Ratios
Klinique Med's financial ratios allow both analysts and investors to convert raw data from Klinique Med's financial statements into concise, actionable information that can be used to evaluate the performance of Klinique Med over time and compare it to other companies across industries.Klinique Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Klinique Med's current stock value. Our valuation model uses many indicators to compare Klinique Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Klinique Med competition to find correlations between indicators driving Klinique Med's intrinsic value. More Info.The Klinique Med is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.13 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for The Klinique Med is roughly 7.93 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Klinique Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Klinique Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Klinique Med Systematic Risk
Klinique Med's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Klinique Med volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Klinique Med correlated with the market. If Beta is less than 0 Klinique Med generally moves in the opposite direction as compared to the market. If Klinique Med Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Klinique Med is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Klinique Med is generally in the same direction as the market. If Beta > 1 Klinique Med moves generally in the same direction as, but more than the movement of the benchmark.
Klinique Med March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Klinique Med help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of The Klinique Med. We use our internally-developed statistical techniques to arrive at the intrinsic value of The Klinique Med based on widely used predictive technical indicators. In general, we focus on analyzing Klinique Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Klinique Med's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.8 | |||
| Information Ratio | 0.0294 | |||
| Maximum Drawdown | 19.52 | |||
| Value At Risk | (4.42) | |||
| Potential Upside | 3.81 |
Complementary Tools for Klinique Stock analysis
When running Klinique Med's price analysis, check to measure Klinique Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klinique Med is operating at the current time. Most of Klinique Med's value examination focuses on studying past and present price action to predict the probability of Klinique Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klinique Med's price. Additionally, you may evaluate how the addition of Klinique Med to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets |